![Figure 2 - Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection - Volume 23, Number 5—May 2017 - Emerging Infectious Diseases journal - CDC Figure 2 - Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection - Volume 23, Number 5—May 2017 - Emerging Infectious Diseases journal - CDC](https://wwwnc.cdc.gov/eid/images/16-1630-F2.jpg)
Figure 2 - Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection - Volume 23, Number 5—May 2017 - Emerging Infectious Diseases journal - CDC
![Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121001567-gr1.jpg)
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect
The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis | PLOS Pathogens
![Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | Immunologic Research Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | Immunologic Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12026-012-8268-8/MediaObjects/12026_2012_8268_Fig1_HTML.gif)
Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | Immunologic Research
Minimizing antibody cross-reactivity in multiplex detection of biomarkers in paper-based point-of-care assays - Nanoscale (RSC Publishing)
![Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection: Cell Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection: Cell](https://www.cell.com/cms/attachment/2045372851/2056782619/fx1.jpg)
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection: Cell
![Strategies to generate cross-reactive antibodies. (a) Cross-panning.... | Download Scientific Diagram Strategies to generate cross-reactive antibodies. (a) Cross-panning.... | Download Scientific Diagram](https://www.researchgate.net/publication/360493985/figure/fig4/AS:1169467665063936@1655834227231/Strategies-to-generate-cross-reactive-antibodies-a-Cross-panning-b-Targeting.png)
Strategies to generate cross-reactive antibodies. (a) Cross-panning.... | Download Scientific Diagram
![Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies - ScienceDirect Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721012146-fx1.jpg)
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies - ScienceDirect
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis | PLOS Pathogens
![A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine](https://www.embopress.org/cms/10.15252/emmm.202215821/asset/3bb23e76-1e64-40b7-ae4f-5d8991a59a13/assets/graphic/emmm202215821-abs-0001-m.png)